PharmaTher Holdings Ltd. (OTCMKTS:PHRRF – Get Free Report) was the recipient of a large growth in short interest during the month of October. As of October 15th, there was short interest totaling 9,702 shares, a growth of 68.1% from the September 30th total of 5,771 shares. Based on an average daily volume of 128,315 shares, the short-interest ratio is currently 0.1 days.
PharmaTher Price Performance
Shares of OTCMKTS PHRRF opened at $0.04 on Tuesday. The business’s 50 day moving average is $0.04 and its two-hundred day moving average is $0.05. PharmaTher has a 52-week low of $0.03 and a 52-week high of $0.12.
About PharmaTher
PharmaTher Inc is a specialty pharmaceutical company focused on the development and commercialization of repurposed and reformulated medicines for neurological and psychiatric conditions. The company’s strategy centers on advancing existing drug compounds through new formulations, delivery methods, or therapeutic applications.
PharmaTher has historically focused on ketamine-based treatments, including programs intended to address conditions such as depression and other mental-health disorders.
See Also
- Five stocks we like better than PharmaTher
- SpaceX Starlink’s Telecom Ground Game Takes Shape
- AST SpaceMobile’s Brazil Breakthrough Could Set the Stage for a Q3 Stock Rebound
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
Receive News & Ratings for PharmaTher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharmaTher and related companies with MarketBeat.com's FREE daily email newsletter.
